@ContrarianCurse@ADHD_Capital Thanks. Agree with another comment on the thread that both likely won’t see material pricing rips though. ENTG seems to suggest they have plenty of under-utilised capacity
@LowAlphaHighVol@Lordvultures Thanks, shall spend some to understand the space. ENTG's quarter and guide was quite uninspiring, wondering if Q is more insulated from competition risks as compared to ENTG?
@Borlaug_ Would $SRT have the most issues of its BPS peers for equipment ramp given that more capacity digestion has to be worked through for SU bioreactors?
@WaterworldCapi1@TMTLongShort Thanks. Think ADSK competition isn't the biggest issue (depends on whether customers have design integration), but agree that it gets smoked on just end-markets deterioration.
@contralculator@marc_slans On ALGN - agree on low downside but curious on how you map out the upside pathway given increased competition intensity (from Angel)/teens growth muted/ASP trending wrong way
@NDS0909 Agree valn is now more interesting & credit mkt vol/duration just depressed. Wondering what can change traders behaviour since MKTX’s pdt innovations feels like a catch-up vs. new, impt functionalities. Think they r approaching D2D w/ pricing strategy, could weigh on fee rates.